-
November 24, 2023 Approval of Kaftrio-Kalydeco for CF children 2-5y.o. in EuropeGood news for CF children!European Commission approved Kaftrio in combination with Kalydeco for the treatment...
-
October 30, 2023 HIT-CF program for rare mutations – August 2023 UpdateResubmission of the "Choices" clinical trial to CTIS, after its initial rejection, is being prepared...
-
September 25, 2023 CHMP positive opinion for Kaftrio/Kalydeco in CF children 2-5 y.o.European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive...
-
June 16, 2022 Promising news for long-term benefits of innovative treatments in Cystic Fibrosis & new clinical studies on rare mutationsPromising news for long-term benefits of innovative treatments in Cystic Fibrosis & new clinical studies...
